Juntao Zhou

Mr. Juntao Zhou


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 June 2025 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
JZJuntao Zhou
Juntao Zhou
JWJianqiao Wang
Jianqiao Wang
LZLijuan Zhang
Lijuan Zhang
CZChengliang Zhang
Chengliang Zhang
CTCheng Tian
Cheng Tian
Liver fibrosis is a common pathological manifestation of various chronic liver diseases, distinguished by the excessive accumulation of the extracellular matrix. If unresolved, liver fibrosis can progress to cirrhosis or hepatocellular carcinoma. Fenestrae are important structures of liver sinusoidal endothelial cells (LSECs) regulating hepatic substance exchange, immune response and hemodynamics. The loss of this structure is usually accompanied by dysfunction of LSECs, which disrupts normal liver physiology by impairing hepatic substance exchange, compromising liver microcirculation, and activating hepatic stellate cells (HSCs). This cascade of events ultimately contributes to the onset and development of liver fibrosis. Oxidative stress, impairment of the NO signaling pathway, actin–myosin complex remodeling and pathological angiogenesis are considered to be the main mechanisms underlying LSEC defenestration. Recently, research on the treatment of LSEC defenestration has made notable progress, and findings suggest a potential value in the application of anti-fibrotic therapies. This article expounds the important correlation between defenestration of LSECs and liver fibrosis, while also reviews therapeutic agents and approaches targeting this pathological process.

Verified
Journal Article
Open access
PDF file
JZJuntao Zhou
Juntao Zhou
LZLijuan Zhang
Lijuan Zhang
JWJianqiao Wang
Jianqiao Wang
CZChengliang Zhang
Chengliang Zhang
CTCheng Tian
Cheng Tian
Liver sinusoidal endothelial cells are highly specialized endothelial cells that contribute to liver homeostasis through their remarkable scavenger function. Through a broad repertoire of scavenger receptors, including mannose receptor, scavenger receptor H, fragment crystallizable gamma receptor IIb, LSECs efficiently clear waste and toxins, altering drug distribution and metabolism. However, this scavenger function can be disrupted by aging, toxins, and transcription factors, thereby promoting the accumulation of harmful substances within the hepatic microenvironment. Impaired LSEC scavenger function contributes to the initiation and progression of multiple liver diseases, such as metabolic dysfunction associated steatotic liver disease, alcoholic liver disease, liver fibrosis, hepatocellular carcinoma, and antibody-based drug-related liver injury. Emerging pharmacological evidence suggests that antioxidant agents, anti-angiogenic strategies and anti-inflammatory interventions may partially restore the expression or function of LSEC scavenger receptors to alleviate liver diseases. In summary, the scavenger function of LSECs serves as a key gatekeeper in liver homeostasis, and targeted modulation of this function holds great potential for the treatment of liver diseases.